 | • レポートコード：GIR-107A12620 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、80ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、前立腺がんのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。前立腺がんの種類別市場規模（化学療法、ホルモン療法、標的療法、免疫療法）、用途別市場規模（55歳以下、55〜75歳、75歳以上）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・前立腺がんの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Astellas, Inc.、AstraZeneca plc、Johnson & Johnson、Sanofi S.A、Bristol Myers Squibb (BMS)、Bayer AG ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：化学療法、ホルモン療法、標的療法、免疫療法 ・用途別分析2016年-2026年：55歳以下、55〜75歳、75歳以上 ・前立腺がんの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・前立腺がんのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・前立腺がんのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・前立腺がんの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・前立腺がんの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Prostate Cancer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Prostate Cancer size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Prostate Cancer market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Prostate Cancer market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Chemotherapy
Hormonal Therapy
Targeted Therapy
Immunotherapy
Market segment by Application, can be divided into
Age Below 55
Age 55-75
Age Above 75
Market segment by players, this report covers
Astellas, Inc.
AstraZeneca plc
Johnson & Johnson
Sanofi S.A
Bristol Myers Squibb (BMS)
Bayer AG
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Prostate Cancer product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Prostate Cancer, with revenue, gross margin and global market share of Prostate Cancer from 2019 to 2021.
Chapter 3, the Prostate Cancer competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Prostate Cancer market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Prostate Cancer research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Prostate Cancer
1.2 Classification of Prostate Cancer by Type
1.2.1 Overview: Global Prostate Cancer Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Prostate Cancer Revenue Market Share by Type in 2020
1.2.3 Chemotherapy
1.2.4 Hormonal Therapy
1.2.5 Targeted Therapy
1.2.6 Immunotherapy
1.3 Global Prostate Cancer Market by Application
1.3.1 Overview: Global Prostate Cancer Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Age Below 55
1.3.3 Age 55-75
1.3.4 Age Above 75
1.4 Global Prostate Cancer Market Size & Forecast
1.5 Global Prostate Cancer Market Size and Forecast by Region
1.5.1 Global Prostate Cancer Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Prostate Cancer Market Size by Region, (2016-2021)
1.5.3 North America Prostate Cancer Market Size and Prospect (2016-2026)
1.5.4 Europe Prostate Cancer Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Prostate Cancer Market Size and Prospect (2016-2026)
1.5.6 South America Prostate Cancer Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Prostate Cancer Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Prostate Cancer Market Drivers
1.6.2 Prostate Cancer Market Restraints
1.6.3 Prostate Cancer Trends Analysis
2 Company Profiles
2.1 Astellas, Inc.
2.1.1 Astellas, Inc. Details
2.1.2 Astellas, Inc. Major Business
2.1.3 Astellas, Inc. Prostate Cancer Product and Solutions
2.1.4 Astellas, Inc. Prostate Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Astellas, Inc. Recent Developments and Future Plans
2.2 AstraZeneca plc
2.2.1 AstraZeneca plc Details
2.2.2 AstraZeneca plc Major Business
2.2.3 AstraZeneca plc Prostate Cancer Product and Solutions
2.2.4 AstraZeneca plc Prostate Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 AstraZeneca plc Recent Developments and Future Plans
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson Prostate Cancer Product and Solutions
2.3.4 Johnson & Johnson Prostate Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Johnson & Johnson Recent Developments and Future Plans
2.4 Sanofi S.A
2.4.1 Sanofi S.A Details
2.4.2 Sanofi S.A Major Business
2.4.3 Sanofi S.A Prostate Cancer Product and Solutions
2.4.4 Sanofi S.A Prostate Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Sanofi S.A Recent Developments and Future Plans
2.5 Bristol Myers Squibb (BMS)
2.5.1 Bristol Myers Squibb (BMS) Details
2.5.2 Bristol Myers Squibb (BMS) Major Business
2.5.3 Bristol Myers Squibb (BMS) Prostate Cancer Product and Solutions
2.5.4 Bristol Myers Squibb (BMS) Prostate Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Bristol Myers Squibb (BMS) Recent Developments and Future Plans
2.6 Bayer AG
2.6.1 Bayer AG Details
2.6.2 Bayer AG Major Business
2.6.3 Bayer AG Prostate Cancer Product and Solutions
2.6.4 Bayer AG Prostate Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Bayer AG Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Prostate Cancer Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Prostate Cancer Players Market Share
3.2.2 Top 10 Prostate Cancer Players Market Share
3.2.3 Market Competition Trend
3.3 Prostate Cancer Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Prostate Cancer Revenue and Market Share by Type (2016-2021)
4.2 Global Prostate Cancer Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Prostate Cancer Revenue Market Share by Application (2016-2021)
5.2 Prostate Cancer Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Prostate Cancer Revenue by Type (2016-2026)
6.2 North America Prostate Cancer Revenue by Application (2016-2026)
6.3 North America Prostate Cancer Market Size by Country
6.3.1 North America Prostate Cancer Revenue by Country (2016-2026)
6.3.2 United States Prostate Cancer Market Size and Forecast (2016-2026)
6.3.3 Canada Prostate Cancer Market Size and Forecast (2016-2026)
6.3.4 Mexico Prostate Cancer Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Prostate Cancer Revenue by Type (2016-2026)
7.2 Europe Prostate Cancer Revenue by Application (2016-2026)
7.3 Europe Prostate Cancer Market Size by Country
7.3.1 Europe Prostate Cancer Revenue by Country (2016-2026)
7.3.2 Germany Prostate Cancer Market Size and Forecast (2016-2026)
7.3.3 France Prostate Cancer Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Prostate Cancer Market Size and Forecast (2016-2026)
7.3.5 Russia Prostate Cancer Market Size and Forecast (2016-2026)
7.3.6 Italy Prostate Cancer Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Prostate Cancer Revenue by Type (2016-2026)
8.2 Asia-Pacific Prostate Cancer Revenue by Application (2016-2026)
8.3 Asia-Pacific Prostate Cancer Market Size by Region
8.3.1 Asia-Pacific Prostate Cancer Revenue by Region (2016-2026)
8.3.2 China Prostate Cancer Market Size and Forecast (2016-2026)
8.3.3 Japan Prostate Cancer Market Size and Forecast (2016-2026)
8.3.4 South Korea Prostate Cancer Market Size and Forecast (2016-2026)
8.3.5 India Prostate Cancer Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Prostate Cancer Market Size and Forecast (2016-2026)
8.3.7 Australia Prostate Cancer Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Prostate Cancer Revenue by Type (2016-2026)
9.2 South America Prostate Cancer Revenue by Application (2016-2026)
9.3 South America Prostate Cancer Market Size by Country
9.3.1 South America Prostate Cancer Revenue by Country (2016-2026)
9.3.2 Brazil Prostate Cancer Market Size and Forecast (2016-2026)
9.3.3 Argentina Prostate Cancer Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Prostate Cancer Revenue by Type (2016-2026)
10.2 Middle East & Africa Prostate Cancer Revenue by Application (2016-2026)
10.3 Middle East & Africa Prostate Cancer Market Size by Country
10.3.1 Middle East & Africa Prostate Cancer Revenue by Country (2016-2026)
10.3.2 Turkey Prostate Cancer Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Prostate Cancer Market Size and Forecast (2016-2026)
10.3.4 UAE Prostate Cancer Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Prostate Cancer Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Prostate Cancer Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Prostate Cancer Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Prostate Cancer Revenue (USD Million) by Region (2016-2021)
Table 5. Global Prostate Cancer Revenue Market Share by Region (2021-2026)
Table 6. Astellas, Inc. Corporate Information, Head Office, and Major Competitors
Table 7. Astellas, Inc. Major Business
Table 8. Astellas, Inc. Prostate Cancer Product and Solutions
Table 9. Astellas, Inc. Prostate Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. AstraZeneca plc Corporate Information, Head Office, and Major Competitors
Table 11. AstraZeneca plc Major Business
Table 12. AstraZeneca plc Prostate Cancer Product and Solutions
Table 13. AstraZeneca plc Prostate Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 15. Johnson & Johnson Major Business
Table 16. Johnson & Johnson Prostate Cancer Product and Solutions
Table 17. Johnson & Johnson Prostate Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Sanofi S.A Corporate Information, Head Office, and Major Competitors
Table 19. Sanofi S.A Major Business
Table 20. Sanofi S.A Prostate Cancer Product and Solutions
Table 21. Sanofi S.A Prostate Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Bristol Myers Squibb (BMS) Corporate Information, Head Office, and Major Competitors
Table 23. Bristol Myers Squibb (BMS) Major Business
Table 24. Bristol Myers Squibb (BMS) Prostate Cancer Product and Solutions
Table 25. Bristol Myers Squibb (BMS) Prostate Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Bayer AG Corporate Information, Head Office, and Major Competitors
Table 27. Bayer AG Major Business
Table 28. Bayer AG Prostate Cancer Product and Solutions
Table 29. Bayer AG Prostate Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Global Prostate Cancer Revenue (USD Million) by Players (2019-2021)
Table 31. Global Prostate Cancer Revenue Share by Players (2019-2021)
Table 32. Breakdown of Prostate Cancer by Company Type (Tier 1, Tier 2 and Tier 3)
Table 33. Prostate Cancer Players Head Office, Products and Services Provided
Table 34. Prostate Cancer Mergers & Acquisitions in the Past Five Years
Table 35. Prostate Cancer New Entrants and Expansion Plans
Table 36. Global Prostate Cancer Revenue (USD Million) by Type (2016-2021)
Table 37. Global Prostate Cancer Revenue Share by Type (2016-2021)
Table 38. Global Prostate Cancer Revenue Forecast by Type (2021-2026)
Table 39. Global Prostate Cancer Revenue by Application (2016-2021)
Table 40. Global Prostate Cancer Revenue Forecast by Application (2021-2026)
Table 41. North America Prostate Cancer Revenue by Type (2016-2021) & (USD Million)
Table 42. North America Prostate Cancer Revenue by Type (2021-2026) & (USD Million)
Table 43. North America Prostate Cancer Revenue by Application (2016-2021) & (USD Million)
Table 44. North America Prostate Cancer Revenue by Application (2021-2026) & (USD Million)
Table 45. North America Prostate Cancer Revenue by Country (2016-2021) & (USD Million)
Table 46. North America Prostate Cancer Revenue by Country (2021-2026) & (USD Million)
Table 47. Europe Prostate Cancer Revenue by Type (2016-2021) & (USD Million)
Table 48. Europe Prostate Cancer Revenue by Type (2021-2026) & (USD Million)
Table 49. Europe Prostate Cancer Revenue by Application (2016-2021) & (USD Million)
Table 50. Europe Prostate Cancer Revenue by Application (2021-2026) & (USD Million)
Table 51. Europe Prostate Cancer Revenue by Country (2016-2021) & (USD Million)
Table 52. Europe Prostate Cancer Revenue by Country (2021-2026) & (USD Million)
Table 53. Asia-Pacific Prostate Cancer Revenue by Type (2016-2021) & (USD Million)
Table 54. Asia-Pacific Prostate Cancer Revenue by Type (2021-2026) & (USD Million)
Table 55. Asia-Pacific Prostate Cancer Revenue by Application (2016-2021) & (USD Million)
Table 56. Asia-Pacific Prostate Cancer Revenue by Application (2021-2026) & (USD Million)
Table 57. Asia-Pacific Prostate Cancer Revenue by Region (2016-2021) & (USD Million)
Table 58. Asia-Pacific Prostate Cancer Revenue by Region (2021-2026) & (USD Million)
Table 59. South America Prostate Cancer Revenue by Type (2016-2021) & (USD Million)
Table 60. South America Prostate Cancer Revenue by Type (2021-2026) & (USD Million)
Table 61. South America Prostate Cancer Revenue by Application (2016-2021) & (USD Million)
Table 62. South America Prostate Cancer Revenue by Application (2021-2026) & (USD Million)
Table 63. South America Prostate Cancer Revenue by Country (2016-2021) & (USD Million)
Table 64. South America Prostate Cancer Revenue by Country (2021-2026) & (USD Million)
Table 65. Middle East & Africa Prostate Cancer Revenue by Type (2016-2021) & (USD Million)
Table 66. Middle East & Africa Prostate Cancer Revenue by Type (2021-2026) & (USD Million)
Table 67. Middle East & Africa Prostate Cancer Revenue by Application (2016-2021) & (USD Million)
Table 68. Middle East & Africa Prostate Cancer Revenue by Application (2021-2026) & (USD Million)
Table 69. Middle East & Africa Prostate Cancer Revenue by Country (2016-2021) & (USD Million)
Table 70. Middle East & Africa Prostate Cancer Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Prostate Cancer Picture
Figure 2. Global Prostate Cancer Revenue Market Share by Type in 2020
Figure 3. Chemotherapy
Figure 4. Hormonal Therapy
Figure 5. Targeted Therapy
Figure 6. Immunotherapy
Figure 7. Prostate Cancer Revenue Market Share by Application in 2020
Figure 8. Age Below 55 Picture
Figure 9. Age 55-75 Picture
Figure 10. Age Above 75 Picture
Figure 11. Global Prostate Cancer Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Prostate Cancer Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Prostate Cancer Revenue Market Share by Region (2016-2026)
Figure 14. Global Prostate Cancer Revenue Market Share by Region in 2020
Figure 15. North America Prostate Cancer Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Prostate Cancer Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Prostate Cancer Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Prostate Cancer Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Prostate Cancer Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Prostate Cancer Market Drivers
Figure 21. Prostate Cancer Market Restraints
Figure 22. Prostate Cancer Market Trends
Figure 23. Astellas, Inc. Recent Developments and Future Plans
Figure 24. AstraZeneca plc Recent Developments and Future Plans
Figure 25. Johnson & Johnson Recent Developments and Future Plans
Figure 26. Sanofi S.A Recent Developments and Future Plans
Figure 27. Bristol Myers Squibb (BMS) Recent Developments and Future Plans
Figure 28. Bayer AG Recent Developments and Future Plans
Figure 29. Global Prostate Cancer Revenue Share by Players in 2020
Figure 30. Prostate Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 31. Global Top 3 Players Prostate Cancer Revenue Market Share in 2020
Figure 32. Global Top 10 Players Prostate Cancer Revenue Market Share in 2020
Figure 33. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 34. Global Prostate Cancer Revenue Share by Type in 2020
Figure 35. Global Prostate Cancer Market Share Forecast by Type (2021-2026)
Figure 36. Global Prostate Cancer Revenue Share by Application in 2020
Figure 37. Global Prostate Cancer Market Share Forecast by Application (2021-2026)
Figure 38. North America Prostate Cancer Sales Market Share by Type (2016-2026)
Figure 39. North America Prostate Cancer Sales Market Share by Application (2016-2026)
Figure 40. North America Prostate Cancer Revenue Market Share by Country (2016-2026)
Figure 41. United States Prostate Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Canada Prostate Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Mexico Prostate Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Europe Prostate Cancer Sales Market Share by Type (2016-2026)
Figure 45. Europe Prostate Cancer Sales Market Share by Application (2016-2026)
Figure 46. Europe Prostate Cancer Revenue Market Share by Country (2016-2026)
Figure 47. Germany Prostate Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Prostate Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Prostate Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Prostate Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Prostate Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Prostate Cancer Sales Market Share by Type (2016-2026)
Figure 53. Asia-Pacific Prostate Cancer Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Prostate Cancer Revenue Market Share by Region (2016-2026)
Figure 55. China Prostate Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Japan Prostate Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. South Korea Prostate Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. India Prostate Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Southeast Asia Prostate Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Australia Prostate Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South America Prostate Cancer Sales Market Share by Type (2016-2026)
Figure 62. South America Prostate Cancer Sales Market Share by Application (2016-2026)
Figure 63. South America Prostate Cancer Revenue Market Share by Country (2016-2026)
Figure 64. Brazil Prostate Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Argentina Prostate Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Middle East and Africa Prostate Cancer Sales Market Share by Type (2016-2026)
Figure 67. Middle East and Africa Prostate Cancer Sales Market Share by Application (2016-2026)
Figure 68. Middle East and Africa Prostate Cancer Revenue Market Share by Country (2016-2026)
Figure 69. Turkey Prostate Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Saudi Arabia Prostate Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. UAE Prostate Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Methodology
Figure 73. Research Process and Data Source
前立腺がん市場：世界及び中国市場分析・予測（～2024年） Prostate Cancer Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Prostate Cancer industry with a focus on the Chinese market. The report provides key statistics on the market status of the Prostate Cancer manufacturers and is a…- ホルモン抵抗性前立腺がん（HRPCA）市場：世界及び中国市場分析・予測（～2024年） Hormone Refractory Prostate Cancer (HRPCA) Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Hormone Refractory Prostate Cancer (HRPCA) industry with a focus on the Chinese market. The report provides key statistics on the marke…
- 世界のがんホルモン療法剤市場 2021：企業別、地域別、種類・用途別 The Cancer Hormone Therapy Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- 世界の前立腺特異抗原市場 2021：企業別、地域別、種類・用途別 The Prostate Specific Antigen market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…
- 世界のがんホルモン療法薬市場予測（～2024年） Hormone Therapy, (also called hormonal therapy, hormone treatment, or endocrine therapy) is a cancer treatment that blocks or lowers the growth of cancer that uses hormones to grow. Doctors use it to treat some cancers such as breast and prostate cancer. Scope of the Report: The global Cancer Hormon…